Join Now

Author Archives: admin

Kelvyn H. Cullimore Jr Appointed as President & CEO of BioUtah

SALT LAKE CITY, UT (September 28, 2018) – BioUtah today announced that the board of directors has selected Kelvyn H. Cullimore Jr. as its president and CEO. Cullimore will succeed Kelly Slone, who has served in that capacity for the past three years.   Cullimore comes to BioUtah with deep experience in both industry and […]

Posted in Policy News | Leave a comment

ULSS Early Bird Registration Opens September 5th

On November 1, BioUtah will be holding its 9th annual Utah Life Sciences Summit (ULSS). This is the premier conference for companies on the cutting edge of medical innovation, and provides a unique opportunity to connect with national leaders in the life sciences industry. Please join us for keynote speakers, panels, and networking opportunites that […]

Posted in Policy News | Leave a comment

Mountain Pacific Venture Fund secures LP commitment from TY BIO Investment

Salt Lake City, August 1, 2018: Mountain Pacific Venture Partners, a Salt Lake City-based venture capital firm, has closed the first institutional investment into its debut fund, which invests in and supports innovative life science and biotech companies. The investment into Mountain Pacific Venture Fund was made by TY BIO Investment, Inc., a wholly-owned subsidiary […]

Posted in Policy News | Leave a comment

BioUtah Statement on U.S. House of Representatives Passage of  Legislation to Permanently Repeal the Medical Device Tax

FOR IMMEDIATE RELEASE July 25, 2018 BioUtah Statement on U.S. House of Representatives Passage of  Legislation to Permanently Repeal the Medical Device Tax Salt Lake City – BioUtah issued the following statement from President and CEO, Kelly Slone, regarding passage of the Protect Medical Innovation Act of 2017 (H.R. 184) in the U.S. House of […]

Posted in Policy News | Leave a comment

Biomerics Acquires FutureMatrix Interventional

Biomerics LLC, a medical device contract manufacturer headquartered in Salt Lake City, UT is pleased to announce the acquisition of FutureMatrix Interventional, Inc. FMI, located in Athens, TX specializes in the design and manufacture of interventional catheters for the cardiovascular and urology markets.

Posted in Policy News | Leave a comment

Biomerics and ATL Technologies Acquire CRI Medical

Biomerics and ATL Technology, in a joint venture (Biomerics ATL, LLC), announced on Tuesday, April 24, 2018, that they have entered into an agreement under which together they will acquire Catheter Research Inc. (CRI)‘s assets in the Indianapolis and Costa Rica divisions.

Posted in Life Sciences Industry News | Leave a comment